/

Dispatch Bio

Develops universal immunotherapy treatments for solid tumor cancers.

BiotechnologyPharmaceuticals dispatchbio.com ↗

Company facts

Founded: 2022
Employees: 60
Headquarters: United States
Type: Private
Funding: Series A · $216M · 2025